Cybin Inc. (NEO:CYBN) (NYSE: CYBN) provided a corporate update outlining access to capital and upcoming clinical milestones. Cybin stated that it had a potential funding of C$70 million funding through a combination of the previously announced common share purchase agreement and current “at-the-market” equity program. Cybin announced at the end …
Massachusetts-based MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) posted a profit in 2022, an anomaly among U.S. publicly traded cannabis companies which combined for billions in losses. CEO Jon Levine and CFO Susan Villare recently sat down with Green Market Report to talk about how the business positioned itself to weather …
Amid growing concerns about the volatility of the cannabis market and its impact on Tilray’s recent downbeat stock price, Tilray’s CFO Carl Merton engaged directly with shareholders and industry enthusiasts last week in an Ask-Me-Anything session on Reddit. Merton, responding to users under the name “TilrayIR,” fielded questions from users …